Zalcitabine (Oral Route)

Free

E-newsletter

Subscribe to Housecall

Our weekly general interest
e-newsletter keeps you up to date on a wide variety of health topics.

Zalcitabine (Oral Route)

US Brand Names

Description

Zalcitabine (also known as ddC) is used in the treatment of the infection caused by the human immunodeficiency virus (HIV). HIV is the virus that causes acquired immune deficiency syndrome (AIDS).

Zalcitabine (ddC) will not cure or prevent HIV infection or AIDS; however, it helps keep HIV from reproducing and appears to slow down the destruction of the immune system. This may help delay the development of problems usually related to AIDS or HIV disease. Zalcitabine will not keep you from spreading HIV to other people. People who receive this medicine may continue to have other problems usually related to AIDS or HIV disease.

Zalcitabine may cause some serious side effects, including peripheral neuropathy (a problem involving the nerves). Symptoms of peripheral neuropathy include tingling, burning, numbness, or pain in the hands or feet. Zalcitabine may also cause pancreatitis (inflammation of the pancreas). Symptoms of pancreatitis include stomach pain, and nausea and vomiting. Check with your doctor if any new health problems or symptoms occur while you are taking zalcitabine.

Zalcitabine was available only with your doctor's prescription.

HIVID® (zalcitabine) was discontinued by Roche Pharmaceuticals on December 31, 2006 due to the availability of newer HIV medicines.

This product is available in the following dosage forms:

• Tablet

Copyright © 2013 Thomson Healthcare Inc. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.